Providing individualized and high-quality psychedelic-assisted therapy.

SoundMind’s flagship psychedelic treatment center, SoundMind Center in Philadelphia, opened in August 2021; this center offers the gold standard of psychedelic treatment and care. We create innovative psychedelic protocols aimed at increasing equity and access as well as improved therapeutic outcomes. We have treatment and training offerings in Oregon and Jamaica, and are creating additional clinical hubs through partnerships in New York and Colorado.

Mission Statement

Psychedelic-assisted therapies are revolutionizing mental healthcare, providing robust and sustainable relief from a range of difficult-to-treat illnesses. Sadly, the legacies of structural inequality that mar so much of American life are alive and well within our healthcare system, and these vital treatments are on track to be out of reach for the most vulnerable among us.

Black, Indigenous, people of color (BIPOC), LGBTQ individuals, and those who are neurodiverse all experience higher rates of mental illness, yet have lower access to care. These inequities are further compounded by the traumas of discrimination and marginalization these individuals face, and the dearth of culturally-sensitive and identity-affirming care. This is especially true within the psychedelic renaissance, which has been called out for cultural appropriation of indigenous medicine work and an ongoing lack of diversity and inclusion—among researchers, participants in clinical trials, and in the clinicians training to provide these treatments.

Psychedelic-assisted treatments—including those currently available using ketamine, and those using MDMA and psilocybin which are rapidly approaching FDA approval—have immense potential to be agents of change in America. But we must think beyond individualistic frameworks, and recognize that meeting the demands of America’s mental health crisis requires us to heal from trauma, discrimination, and violence that occurs across multiple levels: individual, family, community, and society.

We believe psychedelic-assisted therapies are the pathway toward this healing, but only if equity is baked into how these treatments are designed and delivered. We cannot wait to retrofit innovation; we must lay the groundwork now to ensure that these treatments are affordable, accessible, and affirming to all.

At SoundMind we are hard at work to forge a more inclusive psychedelic medicine movement—we invite you to join us.

We are enhancing access to psychedelic healing through several channels: psychedelic facilitator training, public education, research, and clinical services. Through our coursework, we’re educating the next generation of psychedelic facilitators, providing intensive mentorship to providers nationwide. Through training grants and our mentorship funds, we are making psychedelic facilitator training accessible to clinicians who hold marginalized identities, helping to foster a diverse network of leaders and clinicians in this space. Through our research and clinical work, we are committed to developing psychedelic healing modalities to serve populations who have faced intergenerational trauma, including BIPOC individuals, Jewish descendants of holocaust survivors, and Native Americans with PTSD, among others.